Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
September 30, 2026 0.2936M
June 30, 2026 -0.2229M
March 31, 2026 -0.0937M
December 31, 2025 -0.2508M
September 30, 2025 -0.5061M
June 30, 2025 0.4844M
March 31, 2025 -0.57M
December 31, 2024 0.7364M
September 30, 2024 -0.3293M
June 30, 2024 0.9811M
March 31, 2024 0.7744M
December 31, 2023 0.2897M
September 30, 2023 -0.5705M
June 30, 2023 -0.1221M
March 31, 2023 -0.1868M
December 31, 2022 0.0554M
September 30, 2022 0.129M
June 30, 2022 -1.347M
March 31, 2022 0.148M
December 31, 2021 0.608M
September 30, 2021 -0.2362M
June 30, 2021 -0.3663M
March 31, 2021 0.0947M
December 31, 2020 -0.2134M
September 30, 2020 -0.285M
Date Value
June 30, 2020 -0.0648M
March 31, 2020 -0.87M
December 31, 2019 -0.0842M
September 30, 2019 -2.509M
June 30, 2019 -1.804M
March 31, 2019 -1.118M
December 31, 2018 0.1892M
September 30, 2018 -0.7783M
June 30, 2018 -0.0554M
March 31, 2018 -0.055M
December 31, 2017 -0.0567M
September 30, 2017 -0.0617M
June 30, 2017 -0.0729M
March 31, 2017 -0.0709M
December 31, 2016 -0.008M
September 30, 2016 -0.1589M
June 30, 2016 -0.1437M
March 31, 2016 -0.1104M
December 31, 2015 -0.0519M
September 30, 2015 -0.0294M
June 30, 2015 -0.0436M
March 31, 2015 -0.0551M
December 31, 2014 -0.0067M
September 30, 2014 -0.0024M
June 30, 2014 0.00

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Lexaria Bioscience Corp. -1.635M
XORTX Therapeutics, Inc. -0.5428M
NervGen Pharma Corp. -9.236M
Milestone Pharmaceuticals, Inc. -24.76M
Appili Therapeutics, Inc. -0.5351M